Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 1 10Phase 1/2 9Phase NA 8Phase 3 4Phase EARLY_PHASE1 1

Status

Completed 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 439Stomach Neoplasms 248Carcinoma, Hepatocellular 246Rectal Neoplasms 211Colonic Neoplasms 204Pancreatic Neoplasms 172Esophageal Neoplasms 113Neoplasm Metastasis 75Liver Neoplasms 71Neoplasms 63Esophageal Squamous Cell Carcinoma 63Gastrointestinal Stromal Tumors 36Cholangiocarcinoma 36Gastrointestinal Neoplasms 31Parkinson Disease 4, Autosomal Dominant Lewy Body 25Gallbladder Neoplasms 25Adenocarcinoma Of Esophagus 24Biliary Tract Neoplasms 23Anus Neoplasms 22Adenocarcinoma 21Recurrence 19Bile Duct Neoplasms 19Breast Neoplasms 18Digestive System Neoplasms 17Lung Neoplasms 13Prostatic Neoplasms 12Uterine Cervical Neoplasms 11Carcinoma 11Digestive System Diseases 10Peritoneal Neoplasms 9

Interventions

Gemcitabine 3Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2napabucasin 1PEGPH20 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Pancreatic Ductal × Gastrointestinal × Clear all
NCT03899636 2025-02-12

DIRECT

Angiodynamics, Inc.

Phase 3 Active not recruiting
528 enrolled
Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT02993731 2023-11-15

CanStem111P

Sumitomo Pharma America, Inc.

Phase 3 Completed
1,134 enrolled 18 charts
Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT02715804 2020-07-14

A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma

Halozyme Therapeutics

Phase 3 Terminated
492 enrolled 16 charts
Gastrointestinal

Neoplasm Metastasis, Carcinoma, Pancreatic Ductal

NCT00471146 2012-07-16

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

Pfizer

Phase 3 Completed
630 enrolled 13 charts
Gastrointestinal

Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡